
Breakthrough Drug Cuts Alzheimer’s Risk by 50% in High-Risk Patients
Early and long-term treatment with the drug gantenerumab may cut the risk of Alzheimer’s symptoms in half for people genetically predisposed to the disease, offering hope for preventive therapy. 4o A clinical trial involving individuals genetically …